Ticker

Senestech, Inc. (NASDAQ: SNES - Get Free Report) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 49,411 shares, a growth of 127.9% from the February 12th total of 21,680 shares. Based on an average daily volume of 72,794 shares, the days-to-cover ratio is

SenesTech, Inc. (SNES) Q4 2025 Earnings Call Transcript

SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, will report financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025, after the market close on Thursday, March 12, 2026.

Senestech (NASDAQ: SNES - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability. Valuation and Earnings This table compares Senestech and Omeros"s